Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

Authors:

Abstract
No abstract available
Funding Information
  • EMD Serono
  • Roche
  • Teva Pharmaceutical Industries
  • Sanofi
  • Biogen Idec
  • Genzyme
  • Bayer Schering
  • Novartis
  • Baxter International

This publication has 39 references indexed in Scilit: